SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Non-small Cell Lung Cancer|Colorectal Cancer|Breast Cancer
Interventions: DIAGNOSTIC_TEST: Guardant360
Sponsor: Guardant Health, Inc.